Anti-denv3 antibodies
US-2026070961-A1 · Mar 12, 2026 · US
Takeda Vaccines Inc holds 165 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 165 |
| Recent patents | 50 |
| First publication | Jan 8, 2015 |
| Latest publication | Mar 12, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026070961-A1 · Mar 12, 2026 · US
US-2025381261-A1 · Dec 18, 2025 · US
US-12479891-B2 · Nov 25, 2025 · US
US-2025349001-A1 · Nov 13, 2025 · US
US-2025342705-A1 · Nov 6, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026070961-A1 · Mar 12, 2026 · US
US-2025381261-A1 · Dec 18, 2025 · US
US-12479891-B2 · Nov 25, 2025 · US
US-2025349001-A1 · Nov 13, 2025 · US
US-2025342705-A1 · Nov 6, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K39/12 | 130 |
| A61P31/14 | 113 |
| Y02A50/30 | 94 |
| C12N7/00 | 92 |
| C12N2770/24134 | 77 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 157 |
| Human Necessities | 151 |
| Cross-Sectional Technologies | 94 |
| Physics | 18 |
| Operations & Transport | 4 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.